Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04830137
Title A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nurix Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California Irvine Orange California 92868 United States Details
University of California San Francisco Medical Center San Francisco California 94143 United States Details
Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists Sarasota Florida 34203 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20814 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45267 United States Details
OSU Wexner Medical Center Columbus Ohio 43210 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
Baylor University Medical Center Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field